UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 160 filers reported holding UNIQURE NV in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $205,134 | -67.0% | 17,900 | -46.4% | 0.00% | -100.0% |
| Q2 2022 | $622,000 | +5.4% | 33,378 | +2.1% | 0.00% | 0.0% |
| Q1 2022 | $590,000 | -13.0% | 32,678 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $678,000 | -53.9% | 32,678 | -28.9% | 0.00% | -50.0% |
| Q3 2021 | $1,472,000 | +10.3% | 45,978 | 0.0% | 0.00% | +100.0% |
| Q2 2021 | $1,334,000 | -23.4% | 45,978 | -11.0% | 0.00% | -50.0% |
| Q1 2021 | $1,741,000 | +21.1% | 51,678 | +29.8% | 0.00% | 0.0% |
| Q4 2020 | $1,438,000 | +51.8% | 39,800 | +54.9% | 0.00% | +100.0% |
| Q3 2020 | $947,000 | +50.1% | 25,700 | +83.6% | 0.00% | 0.0% |
| Q2 2020 | $631,000 | +28.0% | 14,000 | +34.6% | 0.00% | 0.0% |
| Q1 2020 | $493,000 | +43.3% | 10,400 | +116.7% | 0.00% | – |
| Q4 2019 | $344,000 | – | 4,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |